Literature DB >> 25133809

Stratification of patients with COPD according to the 2011 GOLD report.

Iwona Grzelewska-Rzymowska1, Joanna Patora-Mikołajczyk, Paweł Górski.   

Abstract

INTRODUCTION: The authors aimed to compare the distribution of COPD based on the new GOLD grading with stadium based exclusively on spirometry.
MATERIAL AND METHODS: Eligible patients had an average age of 64.8 years and smoked at least 10 pack-years. COPD was defined according to GOLD fixed cut-off criterion FEV1/FVC < 0.70. In all patients postbronchodilator spirometry was performed. Categories were defined with the mMRC dyspnoea scale and CAT scale. COPD exacerbations in the previous year and lung function were evaluated. Statistical comparisons were done using t-student test.
RESULTS: 315 COPD patients, 99 (31.4%) women and 216 (68.6%) men, were examined. Mean pack-years in the whole group was 47.1 ± 17.8. In women this figure was less than in men, 43.7 ± 19.2 vs 49.5 ± 16.5 (p > 0.05), respectively. At study entry, 144 subjects (45.7%) were current smokers, and the majority of them (n-87, 60.4%) belonged to category D - 26/66 (54.5%) women and 51/102 (50%) men. Based on spirometry alone, the patients were classified as moderate COPD 144 (45.71%), severe - 154 (48.89%), and very severe 17 (5.4%). According to the 2011 GOLD report stratification, 60 patients (19.04%) were graded as category A, 63 (20%) as category B, 24 (7.62%) as category C, and 168 (53.33%) as category D, although 21 (12.5% of them) were in category B, but the number of exacerbations classified them as category D.
CONCLUSIONS: The COPD population is heterogeneous in reference to the symptoms, value of FEV1, and susceptibility to exacerbations. Clinical symptoms assessed using validated questionnaires characterized COPD patients better than the value of spirometric parameters (which are necessary for diagnosis of this disease). Some patients were difficult to classify, especially those belonging to category C.

Entities:  

Mesh:

Year:  2014        PMID: 25133809     DOI: 10.5603/PiAP.2014.0054

Source DB:  PubMed          Journal:  Pneumonol Alergol Pol        ISSN: 0867-7077


  3 in total

1.  New combined assessment of chronic obstructive pulmonary disease: Utilization, pitfalls, and association with spirometry.

Authors:  Ruchi Dua; Ranjeeta Kumari; Vivek Yadav; Mayur Ranjan; Subodh Kumar; Mayank Mishra; Suryakant Tripathi
Journal:  Lung India       Date:  2019 May-Jun

2.  Influence of pulmonary emphysema on COPD assessment test-oriented categorization in GOLD document.

Authors:  Toshio Suzuki; Yuji Tada; Naoko Kawata; Jun Ikari; Yasunori Kasahara; Yoriko Sakurai; Ken Iesato; Rintaro Nishimura; James West; Koichiro Tatsumi
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-06-19

3.  Impact of changing GOLD guidelines (2007-2011-2017) on assignment of a COPD patient to disease severity category.

Authors:  Marcin Nowak; Grzegorz M Brożek; Jan E Zejda; Mateusz Jankowski; Władysław Pierzchała
Journal:  Postepy Dermatol Alergol       Date:  2018-11-14       Impact factor: 1.837

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.